{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T22:00:36Z","timestamp":1771020036546,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.bbi.2022.09.012","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T13:23:24Z","timestamp":1664198604000},"page":"47-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Purinergic P2X7 receptor antagonist inhibits methamphetamine-induced reward, hyperlocomotion, and cortical IL-7A levels in mice: A role for P2X7\/IL-17A crosstalk in methamphetamine behaviors?"],"prefix":"10.1016","volume":"107","author":[{"given":"Raghava","family":"Potula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor A.","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J.","family":"Meissler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aryan","family":"Shekarabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonita","family":"Wiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saadet","family":"Inan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toby K.","family":"Eisenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott M.","family":"Rawls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bbi.2022.09.012_b0005","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/s41590-020-0776-4","article-title":"Meningeal \u03b3\u03b4 T cells regulate anxiety-like behavior via IL-17a signaling in neurons","volume":"21","author":"Alves de Lima","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbi.2022.09.012_b0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0166-4328(03)00136-0","article-title":"Intra-accumbens protein kinase C inhibitor NPC 15437 blocks amphetamine-produced conditioned place preference in rats","volume":"147","author":"Aujla","year":"2003","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.bbi.2022.09.012_b9000","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/bph.12314","article-title":"Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567","volume":"170","author":"Bhattacharya","year":"2013","journal-title":"Br J Pharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2022.09.012_b9005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1017\/S1461145711001933","article-title":"The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice","volume":"16","author":"Cs\u00f6lle","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.bbi.2022.09.012_b0015","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.bjp.0707265","article-title":"Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states","volume":"151","author":"Donnelly-Roberts","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbi.2022.09.012_b0020","doi-asserted-by":"crossref","first-page":"35804","DOI":"10.1038\/srep35804","article-title":"Involvement of P2X7 receptor signaling on regulating the differentiation of Th17 cells and type II collagen-induced arthritis in mice","volume":"6","author":"Fan","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbi.2022.09.012_b0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12974-016-0553-3","article-title":"Methamphetamine alters microglial immune function through P2X7R signaling","volume":"13","author":"Fernandes","year":"2016","journal-title":"J Neuroinflammation."},{"key":"10.1016\/j.bbi.2022.09.012_b0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drugalcdep.2018.12.022","article-title":"Synthetic cathinone MDPV enhances reward function through purinergic P2X7 receptor-dependent pathway and increases P2X7 gene expression in nucleus accumbens","volume":"197","author":"Gentile","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.bbi.2022.09.012_b0035","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12974-021-02072-8","article-title":"Interactions of neuroimmune signaling and glutamate plasticity in addiction","volume":"18","author":"Gipson","year":"2021","journal-title":"J Neuroinflammation."},{"issue":"7","key":"10.1016\/j.bbi.2022.09.012_b0040","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/eji.200838331","article-title":"Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells","volume":"38","author":"Gu","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.bbi.2022.09.012_b0045","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s12035-014-9031-z","article-title":"Role of P2X7 Receptor in an Animal Model of Mania Induced by D-Amphetamine","volume":"53","author":"Gubert","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.bbi.2022.09.012_b0050","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s12035-019-01817-0","article-title":"P2X7 Purinergic Receptor Is Involved in the Pathophysiology of Mania: a Preclinical Study","volume":"57","author":"Gubert","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.bbi.2022.09.012_b0055","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.4049\/jimmunol.2100550","article-title":"The Purinergic Receptor P2X4 Promotes Th17 Activation and the Development of Arthritis","volume":"208","author":"Hamoudi","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2022.09.012_b0060","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s00213-017-4568-y","article-title":"Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG)","volume":"234","author":"Hicks","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2022.09.012_b0065","doi-asserted-by":"crossref","unstructured":"Hutchinson MR, Watkins LR. Why is neuroimmunopharmacology crucial for the future of addiction research? Neuropharmacology 2014; 76 Pt B(0 0):218-227.","DOI":"10.1016\/j.neuropharm.2013.05.039"},{"key":"10.1016\/j.bbi.2022.09.012_b0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbi.2016.08.015","article-title":"Chemokines and cocaine: CXCR4 receptor antagonist AMD3100 attenuates cocaine place preference and locomotor stimulation in rats","volume":"62","author":"Kim","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bbi.2022.09.012_b0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13041-020-00726-x","article-title":"Interleukin-17 induced by cumulative mild stress promoted depression-like behaviors in young adult mice","volume":"14","author":"Kim","year":"2021","journal-title":"Mol Brain."},{"issue":"3","key":"10.1016\/j.bbi.2022.09.012_b0085","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1016\/S0014-2999(00)00731-7","article-title":"Suppression of feeding-evoked dopamine release in the rat nucleus accumbens by the blockade of P(2) purinoceptors","volume":"406","author":"Kittner","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbi.2022.09.012_b0090","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0306-4522(00)00555-8","article-title":"The purinergic P2 receptor antagonist pyridoxalphosphate-6-azophenyl-2'4'-disulphonic acid prevents both the acute locomotor effects of amphetamine and the behavioural sensitization caused by repeated amphetamine injections in rats","volume":"102","author":"Kittner","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2022.09.012_b0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coph.2008.12.003","article-title":"Glutamate and reinstatement","volume":"9","author":"Knackstedt","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2022.09.012_b0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3940(99)00206-2","article-title":"Adenosine 5'-triphosphate-induced dopamine release in the rat nucleus accumbens in vivo","volume":"265","author":"Kr\u00fcgel","year":"1999","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.bbi.2022.09.012_b0105","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/1098-2396(20010301)39:3<222::AID-SYN1003>3.0.CO;2-R","article-title":"Mechanisms of adenosine 5'-triphosphate-induced dopamine release in the rat nucleus accumbens in vivo","volume":"39","author":"Kr\u00fcgel","year":"2001","journal-title":"Synapse"},{"issue":"6","key":"10.1016\/j.bbi.2022.09.012_b0110","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/1756-185X.13529","article-title":"Interleukin-6 and interleukin-17 are related to depression in patients with rheumatoid arthritis","volume":"22","author":"Li","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.bbi.2022.09.012_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114472","article-title":"P2X7 receptors in the central nervous system","volume":"187","author":"Miras-Portugal","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbi.2022.09.012_b0120","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00429-016-1322-x","article-title":"Methamphetamine self-administration modulates glutamate neurophysiology","volume":"222","author":"Mishra","year":"2017","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.bbi.2022.09.012_b0125","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbi.2019.09.017","article-title":"Chemokine CCR5 and cocaine interactions in the brain: Cocaine enhances mesolimbic CCR5 mRNA levels and produces place preference and locomotor activation that are reduced by a CCR5 antagonist","volume":"83","author":"Nayak","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.bbi.2022.09.012_b0130","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1124\/pr.112.007419","article-title":"Intracranial self-stimulation to evaluate abuse potential of drugs","volume":"66","author":"Negus","year":"2014","journal-title":"Pharmacol. Rev."},{"issue":"10","key":"10.1016\/j.bbi.2022.09.012_b0135","first-page":"53","article-title":"Involvement of the chemokine CCL3 and the purinoceptor P2X7 in the spinal cord in paclitaxel-induced mechanical allodynia","volume":"15","author":"Ochi-ishi","year":"2014","journal-title":"Mol. Pain."},{"key":"10.1016\/j.bbi.2022.09.012_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.662935","article-title":"Role of P2X7 Receptors in Immune Responses During Neurodegeneration","volume":"15","author":"Oliveira-Giacomelli","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbi.2022.09.012_b0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neulet.2017.11.042","article-title":"Upregulation of CCL7 and CCL2 in reward system mediated through dopamine D1 receptor signaling underlies methamphetamine-induced place preference in mice","volume":"665","author":"Saika","year":"2018","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.bbi.2022.09.012_b0155","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1021\/acschemneuro.9b00225","article-title":"Methamphetamine Activates Toll-Like Receptor 4 to Induce Central Immune Signaling within the Ventral Tegmental Area and Contributes to Extracellular Dopamine Increase in the Nucleus Accumbens Shell","volume":"10","author":"Wang","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"12","key":"10.1016\/j.bbi.2022.09.012_b0160","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/nm.2242","article-title":"Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R","volume":"16","author":"Wilhelm","year":"2010","journal-title":"Nat. Med."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159122003877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159122003877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:17:34Z","timestamp":1760170654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159122003877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":32,"alternative-id":["S0889159122003877"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2022.09.012","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Purinergic P2X7 receptor antagonist inhibits methamphetamine-induced reward, hyperlocomotion, and cortical IL-7A levels in mice: A role for P2X7\/IL-17A crosstalk in methamphetamine behaviors?","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2022.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}